Correlation Between Volaris and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Volaris and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Volaris and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Volaris and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Volaris and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Volaris with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Volaris and Mineralys Therapeutics,.

Diversification Opportunities for Volaris and Mineralys Therapeutics,

-0.57

Correlation Coefficient

Volaris  Mineralys Therapeutics,

Excellent diversification

The 3 months correlation between Volaris and Mineralys is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Volaris and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Volaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Volaris are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Volaris i.e., Volaris and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between Volaris and Mineralys Therapeutics,

Given the investment horizon of 90 days Volaris is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Volaris is 1.38 times less risky than Mineralys Therapeutics,. The stock trades about -0.01 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  1,600  in Mineralys Therapeutics, Common on October 11, 2024 and sell it today you would lose (480.00) from holding Mineralys Therapeutics, Common or give up 30.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	97.17%
Values	Daily Returns

Volaris  vs.  Mineralys Therapeutics, Common

Volaris

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Volaris are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Volaris unveiled solid returns over the last few months and may actually be approaching a breakup point.

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Volaris and Mineralys Therapeutics,

The main advantage of trading using opposite Volaris and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Volaris position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind Volaris and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.